International Association for the Study of Lung Cancer

04/08/2026

Before taking the stage for the Heine H. Hansen Award Lecture at ELCC 2026, Dr. Antonio Passaro shared a meaningful tribute to his colleague and mentor, Prof. Filippo de Marinis.

Read more:

Prior to delivering the Heine H. Hansen Award Lecture at ELCC 2026, Dr. Antonio Passaro shared a personal tribute dedicated to his colleague and mentor, Prof. Filippo de Marinis.

04/07/2026

What does lung cancer care look like in India, and where are the biggest gaps?

In today's Lung Cancer Considered episode, Dr. Narjust Florez talks with Sanjeev Sharma and Vandana Mahajan about challenges in diagnosis, access, and treatment, and how Lung Connect India is making a difference through patient support, advocacy, and community.

🎧 Tune in: https://bit.ly/4v7OQff

04/06/2026

His work touched countless lives across the global lung cancer community.

Dr. Masahiro Tsuboi was not only a pioneering thoracic surgeon and researcher, but also a dedicated mentor and leader whose contributions continue to shape patient care today.

Take a moment to reflect on his life, legacy, and lasting influence in ILCN:

A highly respected thoracic surgeon and researcher, Dr. Masahiro Tsuboi leaves behind a legacy that will continue to influence lung cancer research and patient care for years to come.

04/05/2026

Don’t miss your chance to save on WCLC26!

Early bird registration is currently open for the IASLC World Conference on Lung Cancer 2026, taking place September 12–15 in Seoul, Republic of Korea.

Join a global community of clinicians, researchers, and advocates to explore the latest advances in lung cancer and connect across disciplines.

IASLC members receive discounted registration rates.

Secure your spot today: https://wclc.iaslc.org/

04/04/2026

📢 There’s still time to submit your abstract!
Join leading researchers, clinicians, and scientists at the IASLC 2026 Hot Topic Meeting in Dublin, Ireland, on June 26–27, and contribute to the evolving conversation on resistance to immunotherapy.

Don’t miss the chance to present your work and connect with peers from around the world.
*Abstract submission closes on April 15

Register & submit now: https://bit.ly/3NbSROT

04/03/2026

Now streaming: Lung Cancer Considered in Korean!

This episode features a case-based discussion on EGFR-mutant NSCLC, moderated by Dr. Chul Kim with insights from Dr. Beung-Chul Ahn and Dr. Hyein Jeon.

🎧 Tune in: https://bit.ly/4lXs59G

04/02/2026

A deeper look at N1 stations could change what we detect.
Dr. Christopher Seder explains how expanded assessment helps identify hidden cancer and strengthen staging precision.

Explore the full story in ILCN:

Dr. Christopher Seder explores how a more extensive N1 station assessment allows thoracic oncologists and pathologists to find more unrecognized cancer and improve staging accuracy.

03/31/2026

At , Ferdinandos Skoulidis and Marina C. Garassino went head-to-head on a critical question: will emerging KRAS combination data be strong enough to support first-line adoption by the end of 2026?

As evidence continues to evolve, debates like this highlight the complexity of translating data into practice.

Read the full recap in ILCN:

Drs. Ferdinandos Skoulidis and Marina C. Garassino went head-to-head over whether emerging KRAS combination data support first-line adoption by year's end.

03/30/2026

⏳ The April 1 deadline to submit your abstract for the IASLC World Conference on Lung Cancer is almost here!

Don't miss the opportunity to share your latest research with a global community of clinicians, researchers, and advocates driving progress in thoracic oncology.

Take advantage of the opportunity to showcase your work on an international stage.

Submit now: https://bit.ly/4bWHqCX

03/30/2026

The deadline to apply for WCLC 2026 awards and programs is coming soon on April 1!

IASLC offers a range of opportunities to support investigators, clinicians, and advocates from around the world in participating in the IASLC World Conference on Lung Cancer.

Opportunities include:
• Early Career Education Awards
• Developing Countries Education Awards
• Nurse or Allied Health Professional Awards
• To***co Control & Smoking Cessation Awards
• International Mentorship Program
• Reviewer Workshop
• Patient Advocate Educational Awards

These unique opportunities support professional growth, networking, and global collaboration in lung cancer research and care.

Learn more and apply:
https://wclc.iaslc.org/awards/

03/29/2026

How do we truly personalize lung cancer treatment?

During the TTLC 2026 Opening Keynote, John V. Heymach shared that it starts with understanding tumor heterogeneity, uncovering what’s really driving the disease in each individual patient.

It’s a complex challenge, but one that’s shaping the future of care.

Catch up on the highlights in ILCN:

During the TTLC 2026 Opening Keynote, Dr. John V. Heymach said personalizing lung cancer therapies will require disentangling heterogeneity to understand the underlying factors driving the disease in each patient.

03/27/2026

At , Ross Camidge shared a deeply personal perspective on lung cancer—reflecting on how it has shaped both his career and his life beyond medicine.

His story is a powerful reminder of the human side of oncology.

Read the full recap in ILCN:

During a special session at TTLC 2026, Dr. Ross Camidge shared his personal journey with lung cancer, discussing its impact on both his professional and personal life.